UPL-10308-62781
2 vaccinations
1 coded response
20 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 240 / VA
- Registered
- 2022-06-24
- Relationship
- Child or adolescent in my care
- Guardian
- R7A-13712-54380
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-22
Dose 1 — Moderna
-
2022-06-24
Registered in v-safe
- 2022-06-24
- 2022-06-25
- 2022-06-26
- 2022-06-27
- 2022-06-28
- 2022-06-29
- 2022-07-15
- 2022-07-20
-
2022-07-27
Dose 2 — Moderna
- 2022-07-27
- 2022-07-28
- 2022-07-29
- 2022-08-01
- 2022-08-03
- 2022-08-10
- 2022-08-17
- 2022-08-24
- 2022-08-31
- 2022-09-07
- 2022-10-26
-
2023-01-27
Survey response — 6 months, dose 2, dependentMedDRA: Gastroenteritis viral, Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-22 | Moderna | No |
| 2 | 2022-07-27 | Moderna | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gastroenteritis viral | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release